Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 23 Genitourinary 9 Other hematologic neoplasm 5 Gynecologic 5 Breast 4 Thoracic 2 Plasma cell 2 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 454 Multiple Endocrine Neoplasia Type 1 166 Pituitary Neoplasms 154 Thyroid Cancer, Papillary 143 Pheochromocytoma 126 Carcinoma, Neuroendocrine 118 Thyroid Neoplasms 103 Neoplasms 89 Carcinoid Tumor 82 Paraganglioma 80 Adrenocortical Carcinoma 74 Thyroid Carcinoma, Anaplastic 67 Adrenal Gland Neoplasms 56 Pancreatic Neoplasms 55 Neoplasm Metastasis 54 Carcinoma, Medullary 51 Insulinoma 49 Gastro-enteropancreatic neuroendocrine tumor 49 Carcinoma, Non-Small-Cell Lung 49 Adenoma, Islet Cell 48 Adenocarcinoma, Follicular 45 Breast Neoplasms 43 Colorectal Neoplasms 42 Sarcoma 39 Prostatic Neoplasms 39 Lung Neoplasms 39 Small Cell Lung Carcinoma 38 Melanoma 38 Carcinoma, Hepatocellular 38 Neuroblastoma 37

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡